Loading clinical trials...
Loading clinical trials...
The study is a prospective, multi-center, open-label clinical trial. Study's purpose is to characterize the pharmacokinetics and safety of four oral anti-epileptics drugs (levetiracetam, valproic acid...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Christoph P Hornik, MD MPH
Collaborators
NCT06608966 · Epilepsy in Children, Executive Dysfunction
NCT06455384 · Cardiac Conditions, Connective Tissue Diseases, and more
NCT05140265 · Epilepsy, Status Epilepticus, and more
NCT06059157 · Drug Resistant Epilepsy
NCT04748770 · Kidney Transplant Access, Obese Patients, and more
The Children's Hospital Colorado
Aurora, Colorado
Nemours Alfred I. DuPont Hospital for Children
Wilmington, Delaware
Childrens Healthcare of Atlanta
Atlanta, Georgia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions